European Medicines Agency pulls authorization for AstraZeneca's COVID shot, at company's request

, according to the EU medicines regulator. In an update on the European Medicines Agency's website Wednesday, the regulator said that the approval for AstraZeneca's Vaxzevria had been withdrawn “at the request of the marketing authorization holder.” AstraZeneca's COVID-19 vaccine was first given the nod by the EMA in January 2021.

Insufficient data about how well the vaccine protected older people led some countries to initially restrict its use to younger populations before reversing course. Billions of doses of the AstraZeneca vaccine were distributed to poorer countries through a U.N.-coordinated program, as it was cheaper and easier to produce and distribute.

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

European Medicines Agency pulls authorization for AstraZeneca's COVID shot, at company's requestThe pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled. In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn at the company's request.
출처: AP - 🏆 728. / 51 더 많은 것을 읽으십시오 »